ASHG 2026 has ended. This guide stays up as the record of who was there. Next: ASHG 2027, Oct 26–30, 2027 in Nashville

Oxford Nanopore Technologies at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

Oxford Nanopore Technologies brings 5 presentations to ASHG 2026 in Montréal, and exhibits at Booth 901. Its program centres on long-read sequencing, targeted genomic analysis, population-scale whole-genome studies, and clinically relevant variant and methylation analysis at this meeting. Its presentations include Oxford Nanopore sequencing in UK Biobank, D4Z4 array structure and epigenetics in FSHD, and tools for challenging medically relevant genes.

OrganizationASHG 2026 Attendance
1 Principal Applications Bioinformatician · 1 Senior Bioinformatician, Commercial Applications · 1 Senior Director of Commercial Applications · 1 Associate Director, Genomic Applications Bioinformatics · 1 other presenter
Public company~1,000 people
Oxford Nanopore sells real-time DNA/RNA sequencing devices, flow cells, and analysis software. Its customers include research, clinical, and biopharma teams.
Oxford Nanopore appointed David Miller as chief development and product officer and Conor McKechnie as chief marketing officer.
›
Oxford Nanopore appointed David Miller as chief development and product officer and Conor McKechnie as chief marketing officer.
2026-08 · source
Oxford Nanopore's MATRIX collaboration expanded to national CNS tumour classification across Norway, broadening its clinical sequencing reach.
2026-06 · source
Lonza and Oxford Nanopore launched a direct RNA sequencing solution for GMP mRNA quality control, opening an mRNA-manufacturing market.
2026-05 · source
Source: company newsroom
H1 2026 revenue £116.7M, up 10.5%
›
FY26 guidance is 16-20% constant-currency growth, excluding one-time $20M in licensing revenue. · 2026-08-19
““Group revenue was £116.7 million, which grew by 12.3% on a constant currency basis (CC), and 10.5% on a reported basis” / “FY26 revenue (no change): Constant-currency growth of 16–20%, excluding the $20 million non-recurring revenue””
Source: results release
Booth
Exhibiting at Booth 901
Wed, Oct 219:30am–4:30pmThu, Oct 229:30am–6:15pmFri, Oct 239:30am–4:30pm
Poster
Wed Oct 21
2:30 pm
★ Reviewers’ Choice
Large population-scale WGS with Oxford Nanopore Sequencing in UK Biobank
Collaborators: UK Biobank
Long-read sequencingCopy number/structural variationGenomicsMethylation
Poster
Wed Oct 21
2:30 pm
Profiling the Structure and Epigenetics of D4Z4 Arrays in FSHD Using Oxford Nanopore Sequencing
BioinformaticsLong-read sequencingMethylationMulti-omics
Poster
Wed Oct 21
2:30 pm
Hybridization-capture enrichment and full-length single-cell TCR profiling using Oxford Nanopore sequencing
Immune systemLong-read sequencingSingle-cellTargeted sequencing
Poster
Thu Oct 22
4:15 pm
Evaluation of Oxford Nanopore whole genome methylation sequencing for phenotype inference and association testing
EpigeneticsLong-read sequencingEpigenome-wide association studiesMethylation
Poster
Fri Oct 23
2:30 pm
Attendee
Attendee
Attendee

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Download the full ASHG 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Oxford Nanopore Technologies

Tell us what you sell and we’ll find the people at Oxford Nanopore Technologies most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction